Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as ...

February 2 is observed as Rheumatoid Arthritis Awareness Day to raise awareness about the condition, its causes, symptoms, treatment options, and more ...

1{at}research.gla.ac.uk Background The past decades have seen rapid advances in the treatment of rheumatoid arthritis (RA). In particular, the introduction of biologic and targeted synthetic ...

Rheumatoid arthritis (RA) is an inflammatory, autoimmune condition that affects not only joints but also organs, including eyes. While it can have painful and debilitating effects if left untreated, ...

A link between rheumatoid arthritis and appendicitis has been investigated before, but newer research has not confirmed these findings. Rheumatoid arthritis is an autoimmune disease where the ...

Medically reviewed by Stella Bard, MD Osteoarthritis (OA) and rheumatoid arthritis (RA) are two of the most common types of ...

and low-dose glucocorticoids increase risk for serious infection at a similar magnitude to biologic therapies. Infections are a common, costly and morbid complication for patients with rheumatoid ...

The difference between rheumatoid arthritis and osteoarthritis must be understood so that it is diagnosed on time and ...

The FDA's approval is grounded in an evidence totality and comprehensive data package, which includes outcomes from a study.

“Asthma and rheumatoid arthritis (RA) are both prevalent diseases ... oral corticosteroids, biologics and azathioprine. Ramonell and Wenzel called these findings that eight of nine patients ...

The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...